2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Emulating the natural timing of dopamine receptor activation in Parkinson’s Disease

J. Reynolds, B. Hyland, J. Wickens, E. Tan (Dunedin, New Zealand)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Epidemiological and clinical profile of Parkinson’s disease in Douala

J. Doumbe, H. Bohongwe, Y. Mapoure, C. Kuate (Douala, Cameroon)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Epigenetic silencing in the humanized mouse model of Friedreich ataxia

L. Rodden, K. Gilliam, S. Bidichandani (Oklahoma City, OK, USA)

Genetics (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Estimates of cost and saving effects of increasing rechargeable devices on the sustainability of a deep brain stimulation program

Y. Compta, A. Cámara, P. Roldán, E. Muñoz, J. Rumià, MJ. Marti, F. Valldeoriola (Barcelona, Catalonia)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Evaluating long-term effectiveness of carbidopa/levodopa enteral suspension in advanced Parkinson’s Disease patients: PROviDE study design and baseline characteristics

R. Pahwa, R. Dorsey, P. Kandukuri, Y. Bao, J. Zamudio, I. Pan, Y. Jalundhwala (Kansas City, KS, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Evaluating the Knowledge, Practice and Experience about Management of Parkinson’s Disease among Physiotherapists in Ghana: A Cross sectional Survey

M. Agoriwo (Accra, Ghana)

Education in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Evaluation clinical-biochemical features of Parkinson’s disease

D. Daminov, G. Rakhmatullaeva (Tashkent, Uzbekistan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Evaluation of apathy before and after subthalamic nucleus deep brain stimulation therapy in advanced Parkinson’s disease patients

S. Caferova, O. Gönül, D. Gunal (Istanbul, Turkey)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Evaluation of the interaction between safinamide and opicapone in Parkinson’s disease patients with fluctuations

J. Garcia-Caldentey, MA. Prats-Sedano, I. Legarda-Ramirez, E. Estelrich-Peyret, B. Vives-Pastor, PJ. Garcia (Palma de Mallorca, Spain)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Exercise to improve upper limb function in people with Parkinson’s disease: A systematic review

E. Proud, J. Blennerhassett, J. Tan, K. Miller, M. Morris, J. McGinley (Parkville, Australia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG